A visualized colorimetric detection strategy for heparin in serum using a metal-free polymer nanozyme

A review towards sustainable analyte detection: Biomimetic inspiration in biosensor technology

The branch of biomimetics has witnessed a profound impact on the field of biosensor technology, reflected in sustainable analyte detection. A vast array of biosensor platforms with improved/upgraded performance have been developed and reported. No wonder the motivation from the field of biomimetics has a huge impact on generating detection systems with escalated degrees of manipulation and tunability at different levels. More recently, biomimetic biosensor technology has found potential in constructing bio-inspired materials such as aptamers, MIPs, nanozymes, DNAzymes, Synzymes, etc. to be integrated with biosensor fabrication. The establishment of a sensing setup is not limited to the bioreceptor fabrication; the construction of transducing element using biomimetic material have been reported too. Moreover, to serve a biosensing of target analyte from a fatal diseased sample different biomimetic architectures can be designed that mimic in-vivo microenvironmental surroundings to get an exact microenvironment equivalent to natural conditions leading towards designing of a precise treatment strategy. This research area is ever-evolving as there is a scope for upgradation and refinement due to advancing technologies including nanotechnology, biomimetic nanomaterials, microfluidics, optical sensors, etc. This review is an attempt to comprehend and juxtapose the very primary innovations in the field of biomimetic biosensor technology to realize its comprehensive and wide-range scope and possibilities.

Implications of analytical nanoscience in pharmaceutical and biomedical fields: A critical view

This review summarizes recent progress performed in the design and application of analytical tools and methodologies using nanomaterials for pharmaceutical analysis, and specifically new nanomedicines at distinct phases of development and translation from preclinical to clinical stages. Over the last 10-15 years, a growing number of studies have utilized various nanomaterials, including carbon-based, metallic nanoparticles, polymeric nanomaterials, materials based on biological molecules, and composite nanomaterials as tools for improving the analysis of pharmaceutical products. New and more complex nanomaterials are currently being explored to influence different stages of the analytical process. These materials provide unique properties to support the extraction of analytes in complex samples, increase the selectivity and efficiency of chromatographic separations, and improve the analytical properties of many sensor applications. Indeed, nanomaterials, including electrochemical detection approaches and biosensing, are expanding at a remarkable rate. Furthermore, the analytical performance of numerous approaches to determine drugs in different matrices can be significantly improved in terms of precision, detection limits, selectivity, and time of analysis. However, the quality control and metrological characterization of the currently synthesized nanomaterials still depend on the development of new and improved analytical methodologies, and the application of specific and improved instrumentation. Therefore, there is still much to explore about the properties of nanomaterials which need to be determined even more precisely and accurately.

Nanosensor based approaches for quantitative detection of heparin

Heparin, being a widely employed anticoagulant in numerus clinical complications, requires strict quantification and qualitative screening to ensure the safety of patients from potential threat of thrombocytopenia. However, the intricacy of heparin's chemical structures and low abundance hinders the precise monitoring of its level and quality in clinical settings. Conventional laboratory assays have limitations in sensitivity and specificity, necessitating the development of innovative approaches. In this context, nanosensors emerged as a promising solution due to enhanced sensitivity, selectivity, and ability to detect heparin even at low concentrations. This review delves into a range of sensing approaches including colorimetric, fluorometric, surface-enhanced Raman spectroscopy, and electrochemical techniques using different types of nanomaterials, thus providing insights of its principles, capabilities, and limitations. Moreover, integration of smart-phone with nanosensors for point of care diagnostics has also been explored. Additionally, recent advances in nanopore technologies, artificial intelligence (AI) and machine learning (ML) have been discussed offering specificity against contaminants present in heparin to ensure its quality. By consolidating current knowledge and highlighting the potential of nanosensors, this review aims to contribute to the advancement of efficient, reliable, and economical heparin detection methods providing improved patient care.

Construction of a highly sensitive detection platform for heparin based on a "turn-off" cationic fluorescent dye

A highly sensitive detection platform for heparin was constructed via the utilization of a commercially available cationic fluorescent dye (cresyl violet acetate, CV) as a fluorescence probe. The electrostatic binding between CV and heparin quenched the fluorescence in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic (HEPES) buffer solution (10 mM, pH 7.1). CV was highly selective towards heparin over other potential inferring substances. The detection limit of heparin detection was 5.19 ng/mL, and the linear working range was 0 ∼ 1 μg/mL in HEPES solution. In 1 % serum, the detection platform based on the fluorescence "turn-off" behavior of CV was also successfully constructed with a detection limit of 5.86 ng/mL in the linear range of 0 ∼ 0.8 μg/mL. Moreover, the CV-heparin complex was considered a potential sensor platform for the detection of protamine because of its stronger affinity for heparin and protamine.

π-Conjugated Copper Phthalocyanine Nanoparticles as Highly Sensitive Sensor for Colorimetric Detection of Biomarkers

Though numerous nanomaterials with enzyme-like activities have been utilized as probes and sensors for detecting biological molecules, it is still challenging to construct highly sensitive detectors for biomarkers using polymeric materials. Benefiting from the π-d delocalization effect of electrons, excellent metal-chelating property, high electron transferability, and good chemical stability of π-conjugated phthalocyanine, the design of the copper phthalocyanine-based conjugated polymer nanoparticles (Cu-PcCP NPs) as a colorimetric sensor for a variety of biomarkers is reported. The Cu-PcCP NPs are synthesized through a simple microwave-assisted polymerization, and their chemical structures are thoroughly characterized. The colorimetric results of Cu-PcCP NPs demonstrate excellent peroxidase-like detecting activity and also great substrate selectivity than most of the reported Cu-based nanomaterials. The Cu-PcCP NPs can achieve a detection limit of 4.88 μM for the H₂ O₂ , 4.27 μM for the L-cysteine, and 21.10 μM for the glucose via a cascade catalytic system, which shows comparable detecting sensitivity as that of many earlier reported enzyme-like nanomaterials. Moreover, Cu-PcCP NPs present remarkable resistance to harsh conditions, including high temperature, low pH, and excessive salts. These highly specific π-conjugated copper-phthalocyanine nanoparticles not only overcome the current limitation of polymeric material-based sensors but also provide a new direction for designing next-generation enzyme-like nanomaterial-based colorimetric biosensors.

Biomimetic two-dimensional nanozymes: synthesis, hybridization, functional tailoring, and biosensor applications

Biological enzymes play important roles in mediating the biological reactions in vitro and in vivo due to their high catalytic activity, strong bioactivity, and high specificity; however, they have also some disadvantages such as high cost, low environmental stability, weak reusability, and difficult production. To overcome these shortcomings, functional nanomaterials including metallic nanoparticles, single atoms, metal oxides, alloys, and others have been utilized as nanozymes to mimic the properties and functions of natural enzymes. Due to the development of the synthesis and applications of two-dimensional (2D) materials, 2D nanomaterials have shown high potential to be used as novel nanozymes in biosensing, bioimaging, therapy, logic gates, and environmental remediation due to their unique physical, chemical, biological, and electronic properties. In this work, we summarize recent advances in the preparation and functionalization, as well as biosensor and immunoassay applications of various 2D material-based nanozymes. To achieve this aim, first we demonstrate the preparation strategies of 2D nanozymes such as chemical reduction, templated synthesis, chemical exfoliation, calcination, electrochemical deposition, hydrothermal synthesis, and many others. Meanwhile, the structure and properties of the 2D nanozymes prepared by conjugating 2D materials with nanoparticles, metal oxides, biomolecules, polymers, ions, and 2D heteromaterials are introduced and discussed in detail. Then, the applications of the prepared 2D nanozymes in colorimetric, electrochemical, fluorescent, and electrochemiluminescent sensors are demonstrated.

Ratiometric fluorescence assay for L-Cysteine based on Fe-doped carbon dot nanozymes

In this work, a ratiometric fluorescence method based on nanozyme was fabricated to determine L-Cysteine. Taking silkworm feces as a carbon source, together with Fe³⁺, Fe-doped carbon dots (Fe-CDs) were synthesized through a hydrothermal method. Fe-CDs were able to oxidize the enzyme substrate o-phenylenediamine (OPD) to produce oxidized OPD (Ox-OPD) when H₂O₂ coexisted with them. Based on the fluorescence property of Fe-CDs and Ox-OPD, a dual-emission system was built. Since L-Cysteine contains reductive thiols that can inhibit the production of Ox-OPD, the addition of L-Cysteine caused a decrease in the fluorescence intensity of Ox-OPD. The results showed that the ratio of fluorescence intensities at 450 and 560 nm (I₄₅₀/I₅₆₀) varied linearly with the concentration of L-Cysteine in the range of 0.25-90 μM and the limit of detection is as low as 0.047 μM. Furthermore, using this ratiometric fluorescence system to determine L-Cysteine in serum and tap-water samples, average recoveries were evaluated to reach 98.75%-103.27% with the relative standard deviation of no more than 4.5%. Based on the fluorescence property and nanozyme-like activity, this work provides an inspiration to open a new horizon in using natural carbon source to synthesize CDs and for the application of CDs as a nanozyme.

Nanozyme-based sensing platforms for detection of toxic mercury ions: An alternative approach to conventional methods

Mercury (Hg) is known as a poisonous heavy metal which stimulates a wide range of adverse effects on the human health. Therefore, development of some feasible, practical and highly sensitive platforms would be desirable in determination of Hg²⁺ level as low as nmol L^-1 or pmol L^-1. Different approaches such as ICP-MS, AAS/AES, and nanomaterial-based nanobiosensors have been manipulated for determination of Hg²⁺ level. However, these approaches suffer from expensive instruments and complicated sample preparation. Recently, nanozymes have been assembled to address some disadvantages of conventional methods in the detection of Hg²⁺. Along with the outstanding progress in nanotechnology and computational approaches, pronounced improvement has been attained in the field of nanozymes, recently. To accentuate these progresses, this review presents an overview on the different reports of Hg²⁺-induced toxicity on the different tissues followed by various conventional approaches validated for the determination of Hg²⁺ level. Afterwards, different types of nanozymes like AuNPs, PtNPs for quantitative detection of Hg²⁺ were surveyed. Finally, the current challenges and the future directions were explored to alleviate the limitation of nanozyme-based platforms with potential engineering in detection of heavy metals, namely Hg²⁺. The current overview can provide outstanding information to develop nano-based platforms for improvement of LOD and LOQ of analytical methods in sensitive detection of Hg²⁺ and other heavy metals.

Lost in (Clinical) Translation: Recent Advances in Heparin Neutralization and Monitoring

The heparin family, which includes unfractionated heparin, low-molecular heparin, and fondaparinux, is a class of drugs clinically used as intravenous blood thinners. To date, issues related to both the reversal of anticoagulation and the blood level determination of the anticoagulant at the point-of-care remain: while the only U.S. Food and Drug Administration (FDA) approved antidote for heparin displays serious efficacy and safety drawbacks, the current assays for heparin monitoring are indirect measurements subject to their own limitations and variations. Herein, we provide an update on the numerous recent chemical approaches to tackle these issues, from which it is clear that some new antidotes and sensors for heparin certainly have the potential to exceed current clinical standards. This review aims to review a field that requires close collaborations between physicians, biologists, and chemists in order to foster advances toward clinical translation.